SBT0000-01, A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received A Gene Modified Regulatory T Cell (Treg) Therapeutics

Clinical Trial Grant

Duke Scholars

Principal Investigator Tarannum Jaleel Dermatology

Administered By

Dermatology

Awarded By

Sonoma Biotherapeutics, Inc.

Start Date

January 15, 2026

End Date

January 31, 2047

Administered By

Dermatology

Awarded By

Sonoma Biotherapeutics, Inc.

Start Date

January 15, 2026

End Date

January 31, 2047